1-1 of 1
Xuefeng Hou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mosunetuzumab (Mosun) or glofitamab (Glofit) in combination with golcadomide (Golca) demonstrates a manageable safety profile and encouraging efficacy in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)

Free
Charalambos Andreadis, Irit Avivi, Neta Goldschmidt, William Townsend, Mariana Bastos-Oreiro, Abraham Avigdor, Peter Riedell, Inna Tzoran, Toby Eyre, Pamela McKay, Pau Abrisqueta, Eva Gonzalez Barca, Alejandro Martin Garcia-Sancho, Sara Galimberti, Antonia Kwan, James Relf, Wilfred Leung, Francis Mussai, Connie Ma, Adrien Petel, Patrick Mueller, Xuefeng Hou, Christopher Fox
Journal: Blood
Blood (2025) 146 (Supplement 1): 66.
https://doi.org/10.1182/blood-2025-66
Published: 2025